Evidence map›Paper›PMID 41994847›Full record

ArticleLeukemia research reports2026

Machine learning models in predictive factors for megaloblastic character of macrocytic anemia.

Melek Kechida, Mohamed Kenani, Nader Slama, Manel Mili, Aminetou Salem, Wassim Krit, Ines Khochtali, Sarra Boukhris, Asma Ben Abdallah, Mohamed Hedi Bedoui

Abstract readCase Reports
In one paragraph

Article in Leukemia research reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Melek KechidaDepartment of Internal Medicine and Endocrinology, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia.
Mohamed KenaniDepartment of Internal Medicine and Endocrinology, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia.
Nader SlamaDepartment of Hematology, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia.
Manel MiliDepartment of Informatics, Faculty of Science of Monastir, University of Monastir, Monastir, Tunisia.
Aminetou SalemDepartment of Hematology, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia.
Wassim KritDepartment of Internal Medicine and Endocrinology, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia.
Ines KhochtaliDepartment of Internal Medicine and Endocrinology, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia.
Sarra BoukhrisDepartment of Hematology, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia.
Asma Ben AbdallahDepartment of Informatics, Higher Institute of Computer Sciences and Mathematics of Monastir, University of Monastir, Monastir, Tunisia.
Mohamed Hedi BedouiTechnology and Medical Imaging Laboratory, Faculty of Medicine Monastir, University of Monastir, Monastir, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Differentiating megaloblastic from non-megaloblastic macrocytic anemia usually relies on vitamin B12 and/or B9 assessment and bone marrow examination. In resource-limited regions, these diagnostic tools are not readily available. This study aims to develop a machine learning model to distinguish between these two forms of macrocytic anemia using commonly accessible clinical and laboratory parameters. Methods: A logistic regression model was developed using a dataset containing clinical features and routine laboratory data. Key predictive variables were identified through the SequentialFeatureSelector. The model was optimized using GridSearchCV and validated through stratified 5-fold cross-validation to ensure robust performance. Results: ESR, glossitis, and MCHC were the most influential variables in predicting non-megaloblastic anemia, with respective importance percentages of 23.11 %, 22.07 %, and 13.87 %. Other variables such as LDH (13.77 %), aregenerative status (13.42 %), and limb paresthesia (11.78 %) also contributed significantly to the model, while MCV had a comparatively lower importance (1.98 %). The model demonstrated a high discriminatory ability, with an area under the ROC curve (AUC) of 0.92 and an overall accuracy of 94 %. Learning curve analysis confirmed its stability and consistent performance across varying data sizes. Conclusions: By reducing dependence on specialized diagnostic tests and invasive procedures, this approach is particularly suited for resource-constrained healthcare settings.

Indexed as

AnemiaMachine learningMacrocyticMegaloblasticPrediction

Identifiers

PMID41994847
PMCPMC13080680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.